1 – 43 of 43
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis
(
- Contribution to journal › Article
- 2023
-
Mark
Autoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers in Sweden
(
- Contribution to journal › Article
-
Mark
Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers
(
- Contribution to journal › Article
-
Mark
Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers
(
- Contribution to journal › Article
- 2022
-
Mark
Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country
(
- Contribution to journal › Article
- 2021
-
Mark
Familial risks and proportions describing population landscape of familial cancer
(
- Contribution to journal › Article
-
Mark
Types of second primary cancer influence overall survival in cutaneous melanoma
(
- Contribution to journal › Article
-
Mark
Second primary cancers after gastric cancer, and gastric cancer as second primary cancer
(
- Contribution to journal › Article
-
Mark
Second primary cancers after liver, gallbladder and bile duct cancers, and these cancers as second primary cancers
(
- Contribution to journal › Article
- 2020
-
Mark
Second Primary Cancers in Patients with Invasive and In Situ Squamous Cell Skin Carcinoma, Kaposi Sarcoma, and Merkel Cell Carcinoma : Role for Immune Mechanisms?
(
- Contribution to journal › Article
-
Mark
Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor
(
- Contribution to journal › Article
-
Mark
Incidence differences between first primary cancers and second primary cancers following skin squamous cell carcinoma as etiological clues
(
- Contribution to journal › Article
-
Mark
Association between tumor characteristics and second primary cancers with cutaneous melanoma survival : A nationwide cohort study
(
- Contribution to journal › Article
-
Mark
Second primary cancers in melanoma patients critically shorten survival
(
- Contribution to journal › Article
-
Mark
Second primary cancers in non-Hodgkin lymphoma : Family history and survival
(
- Contribution to journal › Article
- 2019
-
Mark
Familial Associations of Colon and Rectal Cancers With Other Cancers
(
- Contribution to journal › Article
-
Mark
Second primary cancer after female breast cancer : Familial risks and cause of death
(
- Contribution to journal › Article
-
Mark
Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia
(
- Contribution to journal › Article
-
Mark
Types of second primary cancers influence survival in chronic lymphocytic and hairy cell leukemia patients
(
- Contribution to journal › Letter
- 2018
-
Mark
Multiple myeloma : family history and mortality in second primary cancers
(
- Contribution to journal › Letter
-
Mark
Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer : a nationwide, observational follow up study in Sweden
(
- Contribution to journal › Article
-
Mark
Second primary cancers in non-Hodgkin lymphoma : Bidirectional analyses suggesting role for immune dysfunction
(
- Contribution to journal › Article
- 2017
-
Mark
Familial associations of colorectal cancer with other cancers
(
- Contribution to journal › Article
-
Mark
Familial Associations Between Prostate Cancer and Other Cancers
(
- Contribution to journal › Article
-
Mark
Risk of other Cancers in Families with Melanoma : Novel Familial Links
(
- Contribution to journal › Article
-
Mark
Other cancers in lung cancer families are overwhelmingly smoking-related cancers
(
- Contribution to journal › Article
-
Mark
Genetics of gallbladder cancer
(
- Contribution to journal › Letter
-
Mark
Concordant and discordant familial cancer : Familial risks, proportions and population impact
(
- Contribution to journal › Article
-
Mark
Common cancers share familial susceptibility : Implications for cancer genetics and counselling
(
- Contribution to journal › Article
-
Mark
Familial associations of female breast cancer with other cancers
(
- Contribution to journal › Article
-
Mark
Familial associations of male breast cancer with other cancers
(
- Contribution to journal › Article
- 2016
-
Mark
Patterns of metastasis in colon and rectal cancer
(
- Contribution to journal › Article
-
Mark
Location of metastases in cancer of unknown primary are not random and signal familial clustering.
(
- Contribution to journal › Article
-
Mark
Metastatic spread in patients with gastric cancer
(
- Contribution to journal › Article
-
Mark
The epidemiology of metastases in neuroendocrine tumors
(
- Contribution to journal › Article
- 2015
-
Mark
Smoking and body mass index as risk factors for subtypes of cancer of unknown primary.
(
- Contribution to journal › Letter
-
Mark
Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumors.
(
- Contribution to journal › Article
- 2014
-
Mark
Collection and Use of Family History in Oncology Clinics.
(
- Contribution to journal › Letter
-
Mark
Causes of death in patients with extranodal cancer of unknown primary: searching for the primary site
(
- Contribution to journal › Article
- 2013
-
Mark
Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer
(
- Contribution to journal › Article
- 2010
-
Mark
A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapy
(
- Contribution to journal › Article
- 2009
-
Mark
A Recombinant Adenovirus Type 35 Fiber Knob Protein Sensitizes Lymphoma Cells to Rituximab Therapy
2009) 12th Annual Meeting of the American Society of Gene Therapy In Molecular Therapy 17. p.240-240(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells
(
- Contribution to journal › Article